(S)-1-N-Boc-piperazine-2-carboxylic acid, 95.0%, 5g

(4-(Methylthio)phenyl)methanol, 98%, 1g

6-Bromo-1,1,2-trifluorohexene, 97.0%, 1g

Plan phase PLPHi S100x/1.25 oil immersion infinity corrected IOS objective. Working distance 0.36 mm

2-oxobutanedioic acid, 98.0%, 100mg

(Piperidin-4-yl)methanol hydrochloride, 98%, 25g

1-Boc-3-((Methylamino)methyl)azetidine, 95.0%, 100mg

Quinuclidine-4-carboxylic acid hydrochloride, 95.0%, 10g

Methyl 4-((tert-butoxycarbonyl)amino)-3-methoxybenzoate, 98%, 10g

cis-3-(tert-Butoxycarbonylamino)cyclohexanecarboxylic Acid>97.0%(T)1g

Fmoc-Gly-Ser(Psi(Me,Me)pro)-OH, 95%, 25g

5-Amino-2-bromo-4-methylbenzonitrile, 98%, 100mg

(R)-2-((tert-Butoxycarbonyl)amino)-3-cyclohexylpropanoic acid, 95.0%, 10g